Annual Drug Patent Expirations for ZERVIATE
Zerviate is a drug marketed by Nicox Ophthalmics
and is included in one NDA.
The generic ingredient in ZERVIATE is cetirizine hydrochloride. Additional details are available on the cetirizine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com
Annual Drug Patent Expirations for PROMACTA
Promacta is a drug marketed by Novartis Pharms Corp
and is included in two NDAs. It is available from two suppliers. There are twenty-two patents protecting this drug and two Paragraph IV challenges.
This drug has one hundred and twenty-one patent family members in thirty countries.
The generic ingredient in PROMACTA is eltrombopag olamine. Two suppliers are listed for this compound. Additional details are available on the eltrombopag olamine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com
Annual Drug Patent Expirations for TAMIFLU
Tamiflu is a drug marketed by Roche
and is included in two NDAs. It is available from five suppliers. There are two patents protecting this drug and three Paragraph IV challenges.
The generic ingredient in TAMIFLU is oseltamivir phosphate. Five suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com
Annual Drug Patent Expirations for APTIOM
Aptiom is a drug marketed by Sunovion Pharms Inc
and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has sixty-nine patent family members in thirty countries.
The generic ingredient in APTIOM is eslicarbazepine acetate. One supplier is listed for this compound. Additional details are available on the eslicarbazepine acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com
Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare
and is included in one NDA. There are four patents protecting this compound.
This ingredient has ninety-four patent family members in forty-three countries.
Three suppliers are listed for this compound. There is one tentative approval for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com
This chart shows the drugs with the most patents in Greece.
Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.
The companies with the greatest patent coverage in Greece are:
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com
Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare
and is included in one NDA. There are four patents protecting this compound.
This ingredient has ninety-four patent family members in forty-three countries.
Three suppliers are listed for this compound. There is one tentative approval for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com
This chart shows the pharmaceutical companies with the most suppository dosed drugs.
For a different perspective, see the most popular dosage types.
The companies with the most suppository dosed drugs are:
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com